Globe has also announced that Molnupiravir, the investigational drug used to prevent the spread of COVID-19 is now officially available on the HealthNow app. Molnupiravir helped cut the rate of hospitalization and death by half in a trial of mild-to-moderately ill patients who had at least one risk factor for the disease, according to reports. COVID-19 positive patients interested in Molnupiravir may consult with a doctor on the HealthNow app to check eligibility. Read more in our articles including "Globe Group continues internet and health support amid rise of Covid cases" and "Qualcomm Snapdragon 6 Gen 5, Snapdragon 4 Gen 5 announced".
Globe has also announced that Molnupiravir, the investigational drug used to prevent the spread of COVID-19 is now officially available on the HealthNow app. Molnupiravir helped cut the rate of hospitalization and death by half in a trial of mild-to-moderately ill patients who had at least one risk factor for the disease, according to reports.
COVID-19 positive patients interested in Molnupiravir may consult with a doctor on the HealthNow app to check eligibility.
Our coverage of molnupiravir includes: "Globe Group continues internet and health support amid rise of Covid cases"; "Qualcomm Snapdragon 6 Gen 5, Snapdragon 4 Gen 5 announced"; "HUAWEI nova 15 Max globally launched". Each article provides unique insights and information.